Moderate riskFDA DrugClass II

Accord Healthcare levothyroxine 300 mcg recalled for subpotency

Accord Healthcare is recalling one lot of Levothyroxine Sodium 300 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid medication, and subpotent tablets may not work as intended to treat thyroid conditions.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have lot #D2402337 with expiration date 10/31/2026 (NDC 16729-458-15).
  2. Contact your pharmacy or doctor if you have this lot — do not stop taking your medication without medical guidance.
  3. Your pharmacist can verify your prescription and provide a replacement if needed.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 12 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Classification
Class II
Recall number
D-0786-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15. Subpotent Drug Lot #: D2402337, Exp. Date 10/31/2026. Distribution: Nationwide within the United States Affected quantity: N/A
Hazard
Subpotent Drug

12 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug